Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:ABZ NASDAQ:ASND TSE:SVB CVE:TORQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABZAsiaBaseMetalsC$0.06+9.1%C$0.04C$0.03▼C$0.11C$2.98M0.6224,621 shs22,000 shsASNDAscendis Pharma A/S$169.90-4.1%$169.61$111.09▼$183.00$10.83B0.38506,841 shs617,646 shsSVBSilver Bull ResourcesC$0.28-6.7%C$0.25C$0.11▼C$0.32C$9.33M0.7448,184 shs269,834 shsTORQTorq ResourcesC$0.08C$0.07C$0.05▼C$0.15C$11.13M0.8479,963 shs54,567 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABZAsiaBaseMetals0.00%+9.09%+33.33%0.00%-42.86%ASNDAscendis Pharma A/S+1.03%+0.40%+2.49%+7.36%+27.88%SVBSilver Bull Resources0.00%-1.64%+20.00%+114.29%+114.29%TORQTorq Resources0.00%+14.29%+6.67%+45.45%-11.11%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABZAsiaBaseMetalsN/AN/AN/AN/AN/AN/AN/AN/AASNDAscendis Pharma A/S3.7341 of 5 stars4.53.00.00.03.51.70.6SVBSilver Bull ResourcesN/AN/AN/AN/AN/AN/AN/AN/ATORQTorq ResourcesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABZAsiaBaseMetals 0.00N/AN/AN/AASNDAscendis Pharma A/S 3.00Buy$223.0731.29% UpsideSVBSilver Bull Resources 0.00N/AN/AN/ATORQTorq Resources 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ABZ, TORQ, ASND, and SVB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/11/2025ASNDAscendis Pharma A/SCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$213.00 ➝ $243.007/3/2025ASNDAscendis Pharma A/SMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$250.006/13/2025ASNDAscendis Pharma A/SOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$215.00 ➝ $224.006/9/2025ASNDAscendis Pharma A/SBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$201.00 ➝ $216.006/3/2025ASNDAscendis Pharma A/SBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$196.00 ➝ $201.005/12/2025ASNDAscendis Pharma A/SCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$200.00 ➝ $200.005/5/2025ASNDAscendis Pharma A/SMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$180.00 ➝ $250.005/2/2025ASNDAscendis Pharma A/SRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$205.00 ➝ $210.005/2/2025ASNDAscendis Pharma A/SJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$200.00 ➝ $245.005/2/2025ASNDAscendis Pharma A/SWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$181.00 ➝ $212.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABZAsiaBaseMetalsN/AN/AC$0.00 per share125.00C($0.01) per shareN/AASNDAscendis Pharma A/S$393.54M26.39N/AN/A($1.88) per share-90.37SVBSilver Bull ResourcesN/AN/AC$0.03 per share9.72C$0.12 per shareN/ATORQTorq ResourcesN/AN/AC$0.02 per share4.24C($0.01) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABZAsiaBaseMetals-C$337.34K-C$0.01N/A∞N/AN/A61.21%-310.98%N/AASNDAscendis Pharma A/S-$409.12M-$6.28N/A707.92N/A-93.22%N/A-33.29%9/2/2025 (Estimated)SVBSilver Bull Resources-C$118.67K-C$0.01N/A∞N/AN/A-3.07%-2.41%N/ATORQTorq Resources-C$11.66M-C$0.08N/A∞N/AN/A-101,447.17%-114.13%N/ALatest ABZ, TORQ, ASND, and SVB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025ASNDAscendis Pharma A/S-$1.56-$1.66-$0.10-$1.66$98.56 million$123.97 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABZAsiaBaseMetalsN/A2.82%N/AN/AN/AASNDAscendis Pharma A/SN/AN/AN/AN/AN/ASVBSilver Bull ResourcesN/A0.80%N/AN/AN/ATORQTorq ResourcesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABZAsiaBaseMetalsN/A0.020.74ASNDAscendis Pharma A/SN/A1.040.71SVBSilver Bull ResourcesN/A2.101.94TORQTorq Resources-147.040.0810.31Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABZAsiaBaseMetalsN/AASNDAscendis Pharma A/SN/ASVBSilver Bull ResourcesN/ATORQTorq Resources1.39%Insider OwnershipCompanyInsider OwnershipABZAsiaBaseMetals67.78%ASNDAscendis Pharma A/S40.00%SVBSilver Bull Resources9.51%TORQTorq Resources29.71%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABZAsiaBaseMetalsN/A49.69 millionN/ANot OptionableASNDAscendis Pharma A/S1,01761.13 million36.68 millionOptionableSVBSilver Bull Resources333.30 millionN/ANot OptionableTORQTorq ResourcesN/A139.07 millionN/ANot OptionableABZ, TORQ, ASND, and SVB HeadlinesRecent News About These CompaniesTorq Resources Provides Operations UpdateJuly 17 at 11:45 AM | finance.yahoo.comTorq Resources Completes Inaugural Drill Program at Santa Cecilia ProjectJuly 17 at 7:52 AM | tipranks.comTorq Resources Inc.: Torq Resources Completes Extension of Credit FacilityJune 20, 2025 | finanznachrichten.deTorq Completes $3.12 Million Recapitalization TransactionsJune 6, 2025 | messenger-inquirer.comMTorq Resources Completes $3.12 Million Recapitalization TransactionsJune 6, 2025 | juniorminingnetwork.comInfinigate and Torq Announce European Channel Partnership to Distribute Torq HyperSOCMay 27, 2025 | pressat.co.ukPTorq Provides Drilling, Financing, and Corporate UpdateMay 26, 2025 | finance.yahoo.comTorq Resources Completes Drilling Program and Provides Corporate UpdateMay 26, 2025 | tipranks.comTorq Acquires Startup Revrod to Enhance AI SOC CapabilitiesApril 16, 2025 | databreachtoday.comDTorq Resources Inc.: Torq Resources to Raise C$2 Million, Settle Debts and Extends Credit FacilityMarch 24, 2025 | finanznachrichten.deTorq Resources to Raise C$2 Million, Settle Debts and Extends Credit FacilityMarch 24, 2025 | joplinglobe.comJTorq Resources Commences Drilling at Santa Cecilia and Announces Board ChangeFebruary 28, 2025 | juniorminingnetwork.comTorq Resources Inc.: Torq Commences Drilling at Santa Cecilia and Announces Board ChangeFebruary 28, 2025 | finanznachrichten.deTorq Commences Drilling at Santa Cecilia and Announces Board ChangeFebruary 28, 2025 | corsicanadailysun.comCTorq Resources Begins Drilling at Santa Cecilia ProjectFebruary 27, 2025 | tipranks.comTorq Resources Inc.: Torq Resources Announces Santa Cecilia Option and Joint Venture Transaction with Gold Fields Now In EffectJanuary 18, 2025 | finanznachrichten.deTorq Resources Finalizes Joint Venture with Gold Fields for Chilean ProjectJanuary 17, 2025 | tipranks.comTorq Resources Inc.: Torq Resources Shareholders Overwhelmingly Approve Santa Cecilia Joint Venture Transaction at Annual General and Special MeetingJanuary 10, 2025 | finanznachrichten.deTorq Resources Secures Shareholder Approval for Strategic Santa Cecilia Joint VentureJanuary 10, 2025 | tipranks.comTorq Adds Bevy of AI Agents to Automate Cybersecurity WorkflowsJanuary 6, 2025 | securityboulevard.comSNew MarketBeat Followers Over TimeMedia Sentiment Over TimeABZ, TORQ, ASND, and SVB Company DescriptionsAsiaBaseMetals CVE:ABZC$0.06 +0.01 (+9.09%) As of 10:35 AM EasternAsiaBaseMetals Inc. focuses on the exploration and development of precious and base metals properties in Canada. It explores for gold, silver, zinc copper, cobalt, and lithium deposits. The company holds 100% interest in the Gnome project consisting of 1,996 hectares located in British Columbia. AsiaBaseMetals Inc. was incorporated in 2009 and is based in Vancouver, Canada.Ascendis Pharma A/S NASDAQ:ASND$169.90 -7.30 (-4.12%) Closing price 04:00 PM EasternExtended Trading$171.00 +1.10 (+0.65%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.Silver Bull Resources TSE:SVBC$0.28 -0.02 (-6.67%) As of 03:59 PM EasternSilver Bull Resources Inc is an exploration stage company engaged in acquiring and developing mineral properties. The company holds interests in various property concessions in Mexico within a mining district known as the Sierra Mojada District. The main project of the company is the Sierra Mojada Project. Its geographical segments are Mexico, Canada, and others.Torq Resources CVE:TORQC$0.08 0.00 (0.00%) As of 07/17/2025 02:50 PM EasternTorq Resources Inc., a junior exploration company, engages in the acquisition and exploration of mineral properties in the Americas. It has an option to acquire 100% interests in the Margarita iron oxide-copper-gold project covering an area of approximately 1,445 hectares located in the city of Copiapo, Chile; Santa Cecilia gold-copper project, which covers an area of 3,250-hectares located in Chile; and Andrea copper porphyry project that covers an area of 1,200 hectares located in northern Chile. The company was formerly known as Stratton Resources Inc. and changed its name to Torq Resources Inc. in March 2017. Torq Resources Inc. was founded in 1985 and is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
